Antimicrobial resistance: learning lessons from antiparasitic, antibacterial and antimycobacterial drug resistance in low-income settings (2)

4 March, 2019

Hi Neil,

Thanks for sharing. This 'Group 4' of poor prescribing practice - the problem that is principally behavioural - is my personal passion.

I completely agree that a behavioural science solution is required. It's also inherently multi-disciplinary. I'm interested in answering the questions that surround building such a solution:

- What are clinicians and patients really trying to achieve out of an encounter in which an antimicrobial is prescribed unnecessarily?

- How can we make something other than a prescription the easiest way for the clinician and patient to achieve their goals in such a situation?

- How can we give clinicians and patients the confidence not to prescribe? Within that, what is the role of data/evidence? What is the role of design thinking? What is the role of digital technology?

If I had my own laboratory that's what I'd be researching. I'd be interested to hear of any labs that are addressing these questions (so I can come and work with them!).

Best,

David

--

Dr David Neal

(+44) (0)7905 743 305

www.vesalian.com

HIFA profile: David Neal is Founder of Vesalian, United Kingdom. He is a doctor, with a degree in behavioural science with anthropology. He is also working on ways to support shared, data-driven decision-making in healthcare, by making the best information, the easiest information for patients and professionals to access, understand and remember. Email address: david AT vesalian.com